project id: TCGA-SKCM; case submitter id: TCGA-EB-A299; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.74; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.5; age at index: 63; days to birth: -23322; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23322; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 378.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8721/3; primary diagnosis: Nodular melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 45; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-EB-A299-01A-21; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 25.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;